pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›SYNJARDY XR
drug
save

SYNJARDY XR

updated 3mo ago
by Boehringer Ingelheim Corp
community read0 votes

🐶 often sniffed alongside

top 6
  • tagApproval30 co-mentions · 15 sources
  • drugTRIJARDY XR15 co-mentions · 15 sources
  • companyBoehringer Ingelheim Corp15 co-mentions · 15 sources
  • tagSmall Molecule15 co-mentions · 15 sources
  • drug(empagliflozin + metformin hydrochloride ER)15 co-mentions · 15 sources
  • drugSYNJARDY15 co-mentions · 15 sources

all catalysts(0)

nothing on the calendar yet

Trials studying SYNJARDY XR

  • phase3A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failurerecruitingn=6,000
  • phase4Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2not yet recruitingn=34
  • phase2A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Diseaseactive not recruitingn=492
  • phase2A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancerrecruitingn=1,132
  • N/ACLINICAL STUDY TO DETERMINE BIOEQUIVALENCE BETWEEN TWO ORAL MEDICATIONS OF EMPAGLIFLOZIN/METFORMIN IN 5 mg / 850 mg TABLETS UNDER FED CONDITIONS.completedn=42
  • phase3A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heartrecruitingn=4,200
  • phase3EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Diseaserecruitingn=11,800
  • —Comparative Effectiveness of Empagliflozin in the USactive not recruitingn=230,000
more trials →

News(0)

no news has mentioned this drug yet

brand
SYNJARDY XR
generic
EMPAGLIFLOZIN
Data sources
ClinicalTrials.gov
last refreshed 37m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?